EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
Linder M, Glitzner E, Srivatsa S, Bakiri L, Matsuoka K, Shahrouzi P, Dumanic M, Novoszel P, Mohr T, Langer O, Wanek T, Mitterhauser M, Wagner EF, Sibilia M.
Linder M, et al. Among authors: bakiri l.
EMBO Mol Med. 2018 Nov;10(11):e9408. doi: 10.15252/emmm.201809408.
EMBO Mol Med. 2018.
PMID: 30361264
Free PMC article.